AMICOSANTE, Gianfranco
 Distribuzione geografica
Continente #
NA - Nord America 14.052
EU - Europa 7.246
AS - Asia 7.065
SA - Sud America 932
Continente sconosciuto - Info sul continente non disponibili 842
AF - Africa 109
OC - Oceania 16
Totale 30.262
Nazione #
US - Stati Uniti d'America 13.771
SG - Singapore 2.860
CN - Cina 1.530
IE - Irlanda 1.464
IT - Italia 1.392
RU - Federazione Russa 1.203
TR - Turchia 890
BR - Brasile 795
DE - Germania 772
HK - Hong Kong 701
GB - Regno Unito 548
VN - Vietnam 526
UA - Ucraina 439
SE - Svezia 419
FR - Francia 391
FI - Finlandia 291
CA - Canada 137
IN - India 133
BD - Bangladesh 92
NL - Olanda 82
JP - Giappone 76
MX - Messico 53
BE - Belgio 45
AR - Argentina 44
ES - Italia 43
PL - Polonia 38
IQ - Iraq 37
ID - Indonesia 36
ZA - Sudafrica 36
CO - Colombia 27
KR - Corea 22
RO - Romania 22
EC - Ecuador 21
EU - Europa 20
JM - Giamaica 19
MA - Marocco 19
VE - Venezuela 19
UZ - Uzbekistan 18
LT - Lituania 17
PK - Pakistan 17
CZ - Repubblica Ceca 15
IL - Israele 15
SA - Arabia Saudita 15
GT - Guatemala 13
AU - Australia 12
CR - Costa Rica 12
DK - Danimarca 11
NP - Nepal 11
MY - Malesia 10
CH - Svizzera 9
DZ - Algeria 9
PY - Paraguay 9
TN - Tunisia 9
TT - Trinidad e Tobago 9
AE - Emirati Arabi Uniti 8
HN - Honduras 8
JO - Giordania 8
KE - Kenya 8
BO - Bolivia 7
EG - Egitto 7
KG - Kirghizistan 7
OM - Oman 7
PH - Filippine 7
GP - Guadalupe 6
IR - Iran 6
MD - Moldavia 6
PR - Porto Rico 6
AT - Austria 5
CL - Cile 5
HU - Ungheria 5
SC - Seychelles 5
TH - Thailandia 5
TW - Taiwan 5
AL - Albania 4
CW - ???statistics.table.value.countryCode.CW??? 4
DO - Repubblica Dominicana 4
EE - Estonia 4
GR - Grecia 4
KZ - Kazakistan 4
PE - Perù 4
SV - El Salvador 4
AO - Angola 3
AZ - Azerbaigian 3
BG - Bulgaria 3
LB - Libano 3
MK - Macedonia 3
NI - Nicaragua 3
PA - Panama 3
XK - ???statistics.table.value.countryCode.XK??? 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
GA - Gabon 2
KW - Kuwait 2
MT - Malta 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
Totale 29.422
Città #
Jacksonville 1.719
Singapore 1.631
Dublin 1.464
Chandler 1.463
Dallas 1.247
San Jose 1.246
Ashburn 984
Hong Kong 689
Santa Clara 623
Boardman 503
Izmir 489
Council Bluffs 473
The Dalles 394
Nanjing 313
Milan 291
Ann Arbor 284
Wilmington 251
New York 245
Lawrence 229
Princeton 228
Moscow 217
Beijing 188
Seattle 188
Ho Chi Minh City 165
Lauterbourg 159
Columbus 156
Los Angeles 152
Hanoi 128
San Mateo 127
Nanchang 117
Rome 112
São Paulo 86
Munich 83
Woodbridge 82
L'aquila 76
Mountain View 76
Bremen 74
Tokyo 73
Tianjin 65
Shenyang 63
Naples 60
Hebei 57
Verona 55
Düsseldorf 53
Kunming 47
Jiaxing 44
Jinan 44
Brussels 43
Orem 43
Turku 42
Dong Ket 41
Chicago 40
Helsinki 40
Denver 39
Hefei 39
Des Moines 37
Atlanta 36
Dearborn 36
Frankfurt am Main 36
Houston 35
Warsaw 34
Montreal 32
Shanghai 32
Brooklyn 31
Fremont 31
Norwalk 31
Rio de Janeiro 31
Turin 31
Changsha 30
Miano 30
Toronto 30
Phoenix 29
Jakarta 28
San Francisco 28
Chennai 27
Falls Church 27
Zhengzhou 27
Brasília 26
Amsterdam 25
Bari 25
Belo Horizonte 25
Da Nang 24
Lanzhou 24
Guangzhou 22
Johannesburg 21
Ningbo 21
Seoul 21
Washington 21
North Bergen 20
Buffalo 19
L’Aquila 19
Florence 18
Stockholm 18
Falkenstein 17
Haiphong 17
London 17
Mexico City 17
Poplar 17
Palermo 16
Tashkent 16
Totale 18.995
Nome #
OXA-23 Carbapenemase in Multidrug-Resistant Acinetobacter baumannii ST2 Type: First Identification in L'Aquila Hospital (Italy) 218
SOS response in bacteria: Inhibitory activity of lichen secondary metabolites against Escherichia coli RecA protein 203
Ceftibuten stability to active-site serine and metallo-ß-lactamases 200
Influence of L-carnitine on CD95 cross-linking-induced apoptosis and ceramide generation in human cell lines: Correlation with its effects on purified acidic and neutral sphingomyelinases in vitro 190
The 1.5-Å structure of Chryseobacterium meningosepticum zinc β-lactamase in complex with the inhibitor, D-captopril 189
Broad spectrum β-lactamases of citrobacter diversus 184
Ceftaroline in vitro activity against methicillin-resistant Staphylococcus aureus and coagulase-negative Staphylococci: a short report from Italy 183
CTX and its desacetyl derivative (des-CTX): Interaction with some representative β-lactamases and their related pattern of resistance to newer selected clinical isolates 183
Evaluations of the effects of extremely low-frequency electromagnetic fields on growth and antibiotic susceptibility of escherichia coli and pseudomonas aeruginosa 183
A class-A β-lactamase from Pseudomonas stutzeri that is highly active against monobactams and cefotaxime 182
In vitro interaction of usnic acid in combination with antimicrobial agents against methicillin-resistant Staphylococcus aureus clinical isolates determined by FICI and Delta E model methods 181
First Identification of β-Lactamases in Antibiotic-Resistant Escherichia coli, Citrobacter freundii, and Aeromonas spp. Isolated in Stream Macroinvertebrates in a Central Italian Region. 179
Cyclic and acyclic amine oxide alkyl derivatives as potential adjuvants in antimicrobial chemotherapy against methicillin-resistant staphylococcus aureus with an MDR profile 178
Inhibition of the transcriptional repressor LexA: Withstanding drug resistance by inhibiting the bacterial mechanisms of adaptation to antimicrobials 177
Bovine lactoferrin and its tryptic peptides: Antibacterial activity against different species 176
Characterization of a β-lactamase produced in Mycobacterium fortuitum D316 173
Transient disappearance of CD19+/CD5+ B-lymphocyte clone in peripheral blood in a patient with CLL during SARS-CoV-2-related mild disease 173
Cloning and nucleotide sequencing of the gene encoding the ß-lactamase from Citrobacter diversus 170
Antimicrobial susceptibility of clinical isolates of Enterobacteriaceae producing complex β-lactamase patterns including extended-spectrum enzymes 170
Anti-apoptotic and anti-inflammatory activity of Gentiana lutea root extract 170
Kinetic Study of the Effect of Histidines 240 and 164 on TEM-149 Enzyme Probed by β-Lactam Inhibitors. 168
β-lactamase of Mycobacterium fortuitum: Kinetics of production and relationship with resistance to β-lactam antibiotics 168
In vitro antimicrobial activity of pannarin alone and in combination with antibiotics against methicillin-resistant Staphylococcus aureus clinical isolates 167
Identification of bla(IMP-22) in Pseudomonas spp. in urban wastewater and nosocomial environments: biochemical characterization of a new IMP metallo-enzyme variant and its genetic location 166
Interaction between antimicrobial peptides (AMPs) and their primary target, the biomembranes 166
β-Lactamases as major mechanism of resi stance in Gram-negative bacteria. 165
Cloning and characterization of bla(VIM), a new integron-borne metallo- β-lactamase gene from a Pseudomonas aeruginosa clinical isolate 165
Beta-lactamase of Mycobacterium fortuitum: Introduction to the problem and first experimental data on purification and characterization 164
Emergence of blaKPC-3-Tn4401a in Klebsiella pneumoniae ST512 in the municipal wastewater treatment plant and in the university hospital of a town in central Italy. 163
Cytotoxic activity and antioxidant capacity of purified lichen metabolites: an in vitro study 162
CTX-M-type extended-spectrum β-lactamases in Italy: Molecular epidemiology of an emerging countrywide problem 162
Inhibitory Potential of Polyclonal Camel Antibodies against New Delhi Metallo-β-lactamase-1 (NDM-1). 162
E240V substitution increases catalytic efficiency toward ceftazidime in a new natural TEM-type extended-spectrum beta-lactamase, TEM-149, from Enterobacter aerogenes and Serratia marcescens clinical isolates 161
Amino acid replacement at position 228 induces fluctuation in the Ω-loop of KPC-3 and reduces the affinity against oxyimino cephalosporins: Kinetic and molecular dynamics studies 161
QnrB9 in association with TEM-116 extended-spectrum beta-lactamase in Citrobacter freundii isolated from sewage effluent: first report from Italy 160
Kinetic studies on CphA mutants reveal the role of the P158-P172 loop in activity versus carbapenems 160
Identification of new natural CphA metallo-β-lactamases CphA4 and CphA5 in Aeromonas veronii and Aeromonas hydrophila Isolates from municipal sewage in central Italy 158
Interaction of carbapenems and β-lactamase inhibitors towards CTX-M-15 and CTX-M-15G238Cmutant 158
Protolichesterinic acid enhances doxorubicin-induced apoptosis in HeLa cells in vitro 157
Lactobacillus sakei pro-bio65 reduces tnf-α expression and upregulates gsh content and antioxidant enzymatic activities in human conjunctival cells 157
Replacement R164H and V240H by site-directed mutagenesis of TEM-149 ESBL: kinetic analysis of TEM-149H240 and TEM-149H164-H240 laboratory mutants 156
Derivative spectroscopy as a nonperturbative tool to detect the state of liposome-entrapped sulbactam 156
Extremely low frequency (ELF) electromagnetic field (EMF) reduces quercetin-induced apoptosis in K562 cells: possible role of HSP-70 155
Transcription and expression analysis, using lacZ and phoA gene fusions, of Mycobacterium fortuitum β-lactamase genes cloned from a natural isolate and a high-level β-lactamase producer 154
Exploring the role of l10 loop in new delhi metallo-β-lactamase (Ndm-1): Kinetic and dynamic studies 154
Rapid characterization and partial purification of various animal amine oxidases 153
In vitro activity of cefodizime (HR-221) in combination with β-lactamase inhibitors 153
Kinetic profile and molecular dynamic studies show that Y229W substitution in an NDM-1/L209F variant restores the hydrolytic activity of the enzyme toward penicillins, cephalosporins, and carbapenems 153
Characterization of a new TEM-derived β-lactamase produced in a Serratia marcescens strain 152
Interaction of neomycin with human erythrocytes 152
Interactions of biapenem with active-site serine and metallo-β-lactamases 152
Spread of blaCTX-M-type and blaPER-2 β-lactamase genes in clinical isolates from Bolivian hospitals 151
In vitro selection and characterization of mutants in TEM-1-producing Escherichia coli by ceftazidime and ceftibuten 151
Potent inhibitory activity of taniborbactam towards NDM-1 and NDM-1Q119X mutants, and in vitro activity of cefepime/taniborbactam against MBLs producing Enterobacterales 151
High specificity of cphA-encoded metallo-β-lactamase from Aeromonas hydrophila AE036 for carbapenems and its contribution to β-lactam resistance 150
Use of chromatofocusing in purification of proteins 149
Effects of extracts from lactic acid bacteria on tumor cell invasiveness in vitro 149
Characterization of a new extended-spectrum β-lactamase (TEM-87) isolated in Proteus mirabilis during an Italian survey 149
Exploring the role of L209 residue in the active site of NDM-1 a metallo-β-lactamase 149
Encapsulation of ampicillin in reverse-phase evaporation liposomes: a direct evaluation by derivative spectrophotometry 147
Curcumin inhibits the SOS response induced by levofloxacin in Escherichia coli 147
Citrobacter diversus ULA27 produces two forms of a chromosomal β-lactamase 147
Meropenem stability to β-lactamase hydrolysis and comparative in vitro activity against several β-lactamase-producing Gram-negative strains 146
BlaB-15, a new BlaB metallo-β-lactamase variant found in an Elizabethkingia miricola clinical isolate 146
In vitro Activity of Cefiderocol and Comparator Agents tested against Carbapenem-Resistant Acinetobacter baumannii (CRAb) from six Italian laboratories. 145
Prevalence and characterization of metallo-β-lactamases in clinical isolates of Pseudomonas aeruginosa 145
A Two Amino Acid Duplication, L167E168, in the X-Loop Drastically Decreases Carbapenemase Activity of KPC-53, a Natural Class A β-Lactamase 144
Interaction between lichen secondary metabolites and antibiotics against clinical isolates methicillin-resistant staphylococcus aureus strains. 144
Overexpression system and biochemical profile of CTX-M-3 extended-spectrum β-lactamase expressed in Escherichia coli 144
Dynamical aspects of TEM-1 β-Lactamase probed by molecular dynamics 144
Fractionation and characterization of two β-lactamases in Citrobacter diversus ULA-27 strain by chromatofocusing 144
P174E substitution in GES-1 and GES-5 β-lactamases improves catalytic efficiency towards carbapenems. 144
Gliadin and tissue transglutaminase complexes in normal and coeliac duodenal mucosa. 143
Ceftazidime and aztreonam resistance in Providencia stuartii: Characterization of a natural TEM-derived extended-spectrum β-lactamase, TEM-60 143
Structure of In31, a bla(IMP)-containing Pseudomonas aeruginosa integron phyletically related to In5, which carries an unusual array of gene cassettes 143
Natural D240G Toho1 mutant conferring resistance to ceftazidime: biochemical characterization of CTX-M-43 142
Molecular characterization of carbapenem-resistant Klebsiella pneumoniae ST14 and ST512 causing bloodstream infections in ICU and surgery wards of a tertiary University hospital of Verona (Northern Italy): co-production of KPC-3, OXA-48, and CTX-M-15 β-lactamases. 142
Biochemical analysis of TEM-134, a new TEM-type extended-spectrum beta-lactamase variant produced in a Citrobacter koseri clinical isolate from an Italian hospital 141
Kinetic study of laboratory mutants of NDM-1 metallo-β-lactamase and the importance of an isoleucine at position 35 141
Biochemical characterization of TEM-92 extended-spectrum β-lactamase, a protein differing from TEM-52 in the signal peptide 140
Protocetraric and Salazinic Acids as Potential Inhibitors of SARS-CoV-2 3CL Protease: Biochemical, Cytotoxic, and Computational Characterization of Depsidones as Slow-Binding Inactivators 140
Presence of the ica operon in clinical isolates of Staphylococcus epidermidis and its role in biofilm production 139
Characterization of the chromosomal cephalosporinases produced by Acinetobacter Iwoffii and Acinetobacter baumannii clinical isolates 139
Novel TEM-type extended-spectrum β-lactamase, TEM-134, in a Citrobacter koseri clinical isolate 139
Comparative activity of piperacillin/tazobactam against clinical isolates of extended-spectrum β-lactamase-producing enterobacteriaceae 139
Laboratory variants GESG170L, GESG170K, and GESG170H increase carbapenem hydrolysis and confer resistance to clavulanic acid 139
Apoptotic effects of selected strains of lactic acid bacteria on a human T leukemia cell line are associated with bacterial arginine deiminase and/or sphingomyelinase activities 138
Bactericidal activity of levofloxacin and ciprofloxacin on clinical isolates of different phenotypes of Pseudomonas aeruginosa 138
Proteolytic interconversion and N-terminal sequences of the Citrobacter diversus major β-lactamases 138
Evaluation of the Analytical Performances of the Biolabo SOLEA 100 Optical Coagulometer and Comparison with the Stago STA-R MAX Analyser in the Determination of PT, APTT, and Fibrinogen 137
Effect of V88L, M154L and A233V amino acid substitutions on NDM-1 metallo-β-lactamase: kinetic and dynamic studies. 137
The ultraviolet derivative spectrophotometric determination of neutral liposome-entrapped β-lactam antibiotics 137
Purification and biochemical characterization of the VIM-1 metallo-β-lactamase 137
Antibacterial activity of selected metabolites from Chilean lichen species against methicillin-resistant staphylococci 137
In vitro selected fluoroquinolone-resistant mutants of Citrobacter freundii: Analysis of the quinolone resistance acquisition 136
Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum β-lactamase 136
Resistome and Virulome of Multi-Drug Resistant E. coli ST131 Isolated from Residents of Long-Term Care Facilities in the Northern Italian Region 135
Leucocianidine e collagenasi: inibizione dell’attività enzimatica “in vitro” 134
β-Lactamase induction antagonizes β-lactam susceptibilities in Citrobacter diversus and Enterobacter cloacae clinical isolates 134
Use of the chromosomal class A β-lactamase of Mycobacterium fortuitum D316 to study potentially poor substrates and inhibitory β-lactam compounds 134
Totale 15.566
Categoria #
all - tutte 120.602
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.602


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.233 0 0 0 68 61 29 42 308 82 65 92 486
2022/20234.293 314 245 56 463 457 406 2 260 1.899 21 108 62
2023/2024867 143 69 77 91 72 213 21 69 8 25 25 54
2024/20254.856 89 69 415 256 743 483 670 466 876 178 422 189
2025/20268.586 441 890 969 958 902 725 1.376 299 686 780 387 173
2026/20272.873 225 346 710 1.592 0 0 0 0 0 0 0 0
Totale 30.262